Safety of Penbraya during pregnancy
Part of Infections clinical trials.
This study monitors pregnant individuals who received the Penbraya vaccine to check for any safety concerns. It helps ensure the vaccine is safe for you and your baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently pregnant or have been pregnant within the last year.
- You received at least one dose of Penbraya while pregnant or within 30 days before your last period.
- You agree to let your doctors share your medical information with the study team.
- You provide your contact information and your doctor's contact information.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an observational registry that collects information about pregnant people and their babies when MenQuadfi® (a meningitis vaccine) was given during pregnancy or shortly before pregnancy. It helps researchers understand what happens to women and offspring after this vaccine exposure.
This study tests whether giving pregnant women a special tetanus, diphtheria, and pertussis vaccine (TdaP2gen) helps protect their babies from these diseases. Researchers will follow mothers and infants for up to 18 months to measure how well the vaccine works.
This study tests a vaccine that protects against three diseases—diphtheria, tetanus, and whooping cough—given during pregnancy. Researchers want to see if the vaccine is safe for pregnant women and their babies, and whether it helps protect newborns.
This study tests an experimental pneumococcal vaccine in healthy infants. It involves three shots during infancy and a booster around 12-15 months to see if it is safe and how the body responds.
This trial tests two different booster shots for meningitis B in young adults who already got the Bexsero vaccine at least 2.5 years ago. The goal is to see which booster works best to keep you protected.
This study tests whether a new pneumococcal vaccine (which protects against a serious bacterial infection) is safe in healthy 2-month-old infants. Researchers will watch for side effects and help protect future babies from pneumococcal disease.
Hear when a new Meningococcal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.